As of Mar 2020 · from Reg CF Offering (2019) · pre-money + amount raised, not a traded price
Total raised
$1,064,853
Across 1 round since 2019
Latest share price
$1.18
Reg CF Offering (2019) offering price
Financials
FY2017–FY2022 · from SEC filings · hover any figure for its source
$3.6M
−$558K
2017
$3.9M
−$958K
2018
$4.5M
−$500K
2019
$5.8M
−$41K
2020
$6.3M
$97K
2021
$6.9M
$98K
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
Income statement
Revenue
$3,647,718
$3,896,701
$4,536,594
$5,771,573
$6,328,389
$6,854,444
Cost of goods sold
$2,014,995
$2,422,988
$2,060,596
$2,632,124
$2,972,072
$3,452,271
Gross margin
45%
38%
55%
54%
53%
50%
Net income
-$558,039
-$957,618
-$499,764
-$40,987
$97,104
$98,162
Taxes paid
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$416,366
$132,574
$106,121
$153,557
$271,677
$333,358
Accounts receivable
$318,153
$292,841
$379,785
$381,044
$385,971
$345,588
Total assets
$1,806,961
$1,246,284
$1,182,170
$1,384,385
$1,407,373
$1,493,202
Short-term debt
$372,026
$943,890
$1,479,867
$214,000
$536,199
$618,282
Long-term debt
$806,198
$630,276
$529,948
$681,971
$458,595
$337,058
Total liabilities
$1,178,224
$1,574,166
$2,009,815
$895,971
$994,794
$955,340
Other
Headcount
—
20
20
—
20
17
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.